CAPITATION

按人头付费

• 批准号: 7515885
• 负责人: CHARLES L LOPRINZI
• 金额: $ 82.57万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-14 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7515885
• 关键词: Cancer Control; Community Clinical Oncology Program; Funding; Grant; North Central Cancer Treatment Group; Protocols documentation; Rate; Research; Site; Specific qualifier value; United States National Institutes of Health; base; member

Consortium Funds ($750,000). The consortium funding component is utilized to provide reimbursement at the research base as well as at North Central Cancer Treatment Group member sites not having their own CCOP grant. This funding is provided at the rate specified by the NIH; currently $2,000 per case credit, and is restricted to capitation reimbursement for cancer control protocols. Predicting the total funding needed for this component of the grant is dependent on numerous variables such as new protocols coming on-line, closing of existing protocols, and the accrual activity of participating sites. Funding is requested for this submission to support 375 total accruals at all non-CCOP NCCTG sites at the current rate of $2,000 each, for a total request of $750,000.

财团资金（750,000 美元）。财团资金部分用于提供报销 研究基地以及中北部癌症治疗组成员地点没有自己的 CCOP 授予。这笔资金按照 NIH 指定的费率提供；目前每个案例信用额为 2,000 美元， 仅限于癌症控制方案的按人头报销。预测此项目所需的总资金 赠款的组成部分取决于许多变量，例如新协议的上线、项目的结束 现有协议以及参与站点的应计活动。本次提交请求资金 支持所有非 CCOP NCCTG 站点的 375 个总应计费用，当前费率为每个站点 2,000 美元，总请求数 750,000 美元。